Literature DB >> 18809380

Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9.

Jun-Seok Ahn1, Min-kyung Kim, Jang-hee Hahn, Jung-Hyeun Park, Kyeong-Han Park, Byung-Ryul Cho, Seung-Bae Park, Dae-joong Kim.   

Abstract

Tissue transglutaminase (TGase 2) has been reported to have multiple functions in addition to its function as a biological adhesive. To identify its roles, we investigated the effects of TGase 2 on gelatinase activity. The MMP-9 activity of certain cell lines was significantly inhibited with retinoic acid treatment, and this effect was reversed in the presence of a TGase 2 inhibitor. Furthermore, TGase 2 overexpression reduced the MMP-9 protein expression levels and inhibited its activity in both culture media and cell lysate. The decreased mRNA levels of MMP-9 and the results of a promoter assay revealed that TGase 2 may be involved in MMP-9 transcription. Further, data obtained in an immunoprecipitation assay and an electrophoretic mobility shift assay demonstrated that TGase 2 binds to c-Jun and suppresses its binding activity toward AP-1. These results suggest that TGase 2 inhibits MMP-9 via downregulation of MMP-9 transcription activity by blocking the binding of the Jun-fos complex to an AP-1 site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809380     DOI: 10.1016/j.bbrc.2008.09.048

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

Review 3.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

4.  Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.

Authors:  Soner Gundemir; Gozde Colak; Julianne Feola; Richard Blouin; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2012-10-17

Review 5.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 6.  Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2.

Authors:  Kajal Kanchan; Mónika Fuxreiter; László Fésüs
Journal:  Cell Mol Life Sci       Date:  2015-05-06       Impact factor: 9.261

7.  Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.

Authors:  Gozde Colak; Gail V W Johnson
Journal:  Neurobiol Dis       Date:  2011-12-14       Impact factor: 5.996

8.  Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viability.

Authors:  Laura Yunes-Medina; Alex Paciorkowski; Yan Nuzbrokh; Gail V W Johnson
Journal:  Mol Cell Neurosci       Date:  2017-11-29       Impact factor: 4.314

9.  Depletion of astrocytic transglutaminase 2 improves injury outcomes.

Authors:  Alina Monteagudo; Julianne Feola; Heather Natola; Changyi Ji; Christoph Pröschel; Gail V W Johnson
Journal:  Mol Cell Neurosci       Date:  2018-06-30       Impact factor: 4.314

10.  Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.

Authors:  Gozde Colak; Jeffrey W Keillor; Gail V W Johnson
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.